Sector valuations DaShenLin Pharmaceutical Group Co., Ltd.
Stocks
603233
CNE100002RG2
Drug Retailers
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 17.91 CNY | -1.92% |
|
-6.38% | +1.65% |
| 04-24 | Dashenlin Pharma's Q1 Profit Rises 11% | MT |
| 04-24 | Dashenlin Pharma's 2025 Profit Jumps 35%, Revenue Rises 4% | MT |
Main competitors
| P/E (Y) | Price to Book (Y) | PEG (Y) | EV / Sales (Y) | EV / EBITDA (Y) | EV / EBIT (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
 | 13.74x | 2.57x | 0.66x | 0.56x | 4.49x | 7.41x | 5.03% | 3.02B | |
| 18.37x | 1.62x | 2.29x | 0.78x | 12.33x | 13.24x | -.--% | 15.94B | |
| 23.44x | 2.64x | 3.05x | 0.93x | 15.72x | 16.02x | 0.95% | 7.22B | |
| 16.03x | 1.68x | 1.75x | 0.72x | 7.47x | 9.39x | 2.33% | 6.08B | |
| 14.04x | 2.13x | 0.79x | 0.91x | 6.58x | 8.62x | 3.02% | 4.04B | |
| 15.04x | 4.92x | -16.5x | 1.3x | 8x | 14.84x | 5.9% | 3.3B | |
| 15.06x | 6.81x | 2.3x | 0.91x | 6.85x | 9.53x | 4.26% | 3.13B | |
| 37.95x | - | 1.14x | - | - | - | - | 2.5B | |
| 21.42x | 3.75x | 0.93x | 0.62x | 7.94x | 13x | 1.92% | 1.58B | |
| -104.15x | 2.66x | 1.53x | 0.44x | 16.25x | 69.94x | 0.02% | 1.48B | |
| 12.11x | 0.86x | 0.12x | 0.29x | 2.78x | 5.74x | 4.19% | 962M | |
| 14.51x | 2.4x | -0.55x | 0.85x | 6.92x | 14.88x | 5.75% | 920M | |
| 40.36x | 3.85x | -6.2x | 0.94x | 11.78x | 23.2x | - | 870M | |
| 26.42x | 7.2x | 0.98x | 0.96x | 13.04x | 20.22x | 1.35% | 808M | |
| 13.9x | 1.88x | 1.15x | 0.67x | 8.22x | 13.27x | 0.37% | 698M | |
| Average | 11.88x | 3.21x | -0.44x | 0.78x | 9.17x | 17.09x | 2.7% | 3.5B | |
| Weighted average by Cap. | 15.62x | 2.65x | 0.56x | 0.82x | 10.30x | 14.16x | 1.93% |
Select your edition
All financial news and data tailored to specific country editions
